The year was characterised by significant investments in IT infrastructure, warehousing and logistics—both to support the rapid shift towards e‑commerce and to modernise pharmacy solutions for continued growth. During the year, the pharmacy network was also further developed, with a strong focus on locations close to ICA stores.
With just over 400 pharmacies, extensive online operations and a market share of over 32%, Apotek Hjärtat is the largest company in the Swedish pharmacy market. Pharmacy operations complement grocery retail and play an important role in ICA Gruppen’s efforts to achieve a leading position in health.

The goal going forward will be to further strengthen Apotek Hjärtat’s position as the leading player in the Swedish pharmacy market. Top priorities include consolidating the position of the physical pharmacies while continuing to grow and take market share online. A key element of these efforts involves continued integration between the e-commerce channel and the physical pharmacies, and continuing to establish new pharmacies in locations close to ICA.
Customer loyalty will be strengthened further, including through the development of Stammis and increased collaboration with other operations within ICA Gruppen. There will be considerable emphasis on continuing to develop and broaden the customer offering, not least in terms of online shopping. Initiatives encompass development of the private label assortment, service development and a greater focus on health.
A total of eight new pharmacies are planned for 2026, all in locations close to ICA stores in parallel with a high rate of renewal for existing pharmacies.
Streamlining will continue of logistics and staffing, through measures including further automation of the e-commerce warehouse in Norrköping. The enhancement of IT platforms will be completed and new AI-supported solutions will be launched.
Net sales 2025
Operating profit 2025*
Operating margin 2025*
*Excluding items affecting comparability